Lv1
40 积分 2022-11-25 加入
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co‐Expression Patterns: A Double‐Blind, Randomized, Placebo‐Controlled, Phase 2 Trial
28天前
已完结
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study
2个月前
已完结
Treatment of Radiation‐ and Chemotherapy‐Induced Stomatitis
5个月前
已完结
Targeting Legumain As a Novel Therapeutic Strategy in Cancers
6个月前
已完结
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
7个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
7个月前
已完结
Treatment of candidal diaper dermatitis: A double-blind placebo-controlled comparison of topical nystatin with topical plus oral nystatin
8个月前
已完结
A 3-way Cross-over Study of Pregabalin, Placebo, and the Histamine 3 Receptor Inverse Agonist AZD5213 in Combination With Pregabalin in Patients With Painful Diabetic Neuropathy and Good Pain-reporting Ability
9个月前
已完结
A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Pregabalin for Postherpetic Neuralgia in a Population of Chinese Patients
9个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
10个月前
已完结
皖公网安备34019202002308
